Coronary In-Stent Restenosis Treated With Paclitaxel-Coated Balloon vs Uncoated Balloon

Coronary In-Stent Restenosis Treated With Paclitaxel-Coated Balloon vs Uncoated Balloon—Reply

Published:2024-07-09 Issue:2 Volume:332 Page:169
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Yeh Robert W.¹,Kirtane Ajay J.²,

Affiliation:

1. Beth Israel Deaconess Medical Center, Boston, Massachusetts

2. Columbia University Irving Medical Center, Cardiovascular Research Foundation, New York, New York

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jama/articlepdf/2819943/jama_yeh_2024_lr_240040_1720019497.66876.pdf

Reference5 articles.

1. Paclitaxel-coated balloon vs uncoated balloon for coronary in-stent restenosis: the AGENT IDE randomized clinical trial.;Yeh;JAMA,2024

2. Survival after coronary revascularization with paclitaxel-coated balloons.;Scheller;J Am Coll Cardiol,2020

3. Mortality in randomised controlled trials using paclitaxel-coated devices for femoropopliteal interventional procedures: an updated patient-level meta-analysis.;Parikh;Lancet,2023

4. 2018 ESC/EACTS guidelines on myocardial revascularization.;Neumann;Eur Heart J,2019

5. US Food and Drug Administration. UPDATE: Paclitaxel-coated devices to treat peripheral arterial disease unlikely to increase risk of mortality: letter to health care providers. Published July 11, 2023. Accessed April 29, 2024. https://www.fda.gov/medical-devices/letters-health-care-providers/update-paclitaxel-coated-devices-treat-peripheral-arterial-disease-unlikely-increase-risk-mortality

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coronary Drug-Coated Balloons: A Comprehensive Review of Clinical Applications and Controversies;Trends in Cardiovascular Medicine;2024-09